SGS Belgium — Clinical Trial Site

67 Registered trials

12 Currently recruiting

Organisation

SGS Belgium

Location

Edegem, Belgium

Identifier

ORG-100007917

Address

Drie Eikenstraat 655, 2650, Belgium

Departments

#001_00270390: Health & Nutrition
Clinical Pharmacological Unit
Clinical Pharmacology Unit
Clinical Pharmacology Unit Antwerpen
Clinical Research Clinical Pharmacology Unit
CPU
gastroenterology
SGS - Clinical Research
SGS - Clinical Research, Clinical Pharmacology Unit
SGS Belgium NV – Clinical Pharmacology Unit
SGS Clinical Pharmacology Unit
SGS Clinical Research, Clinical Pharmacology Unit
SGS CR - Clinical Pharmacology Unit
SGS Life Science Services - Clinical Research
SGS NV - Clinical Pharmacology Unit
SGS-Clinical Research CPU

Clinical trials at this site (67)

Search interface

A study to investigate the bioavailability of the SAR444656 test formulation and the food effect on the SAR444656 test formulation in health… Ended

2024-515621-28-00 Healthy Volunteer 3 2025-04-17
A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants Ended

2025-520454-11-00 Alzheimer 1 2025-03-20
A clinical study of MK-2420 in healthy people (MK-2420-002) Ended

2024-516548-25-00 Rheumatoid arthritis 3 2025-03-12
Not applicable Ended

2024-518150-17-00 Non-cystic fibrosis bronchiectasis 3 2025-03-10
Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults. Ended

2024-515285-14-00 Healthy Volunteers 1 2025-03-04
A clinical study of MK-2828 in healthy people (MK-2828-002) Ended

2024-518229-13-00 Atherosclerosis 3 2025-01-21
A study to test how different doses of BI 3731579 are tolerated by healthy people Ended

2024-517209-95-00 Healthy volunteer trial 3 2024-12-11
A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants Ended

2024-517511-70-00 not applicable 3 2024-12-04
Evaluation of safety, side effects and how the inhaled drug CHF10073 is absorbed, modified and removed from the body when administered alone… Ended

2024-515442-17-00 Pulmonary fibrosis 1 2024-12-03
Evaluation of the CHF 5993 concentration in blood, after inhalation with two different devices, (NEXThaler® versus pMDI), with and without A… Ended

2024-512792-13-00 Asthma 3 2024-11-13
A Study to Learn How Safe EV25 is, the Amount of EV25 in the Body Over a Period of Time, and the Effects of EV25 on the Body in Adult Health… Ended

2024-514832-26-00 Virus Influenza 7 2024-11-12
A clinical study of MK-3508 in healthy people (MK-3508-006) Ended

2024-516619-26-00 Respiratory syncytial virus infection 3 2024-11-04
A clinical study of MK-1403 in healthy men (MK-1403-004) Ended

2024-514629-52-00 Atherosclerosis 3 2024-10-28
A study to test how well different doses of BI 3810477 are tolerated by healthy men Ended

2024-513419-28-00 Healthy volunteer trial 1 2024-10-22
A clinical study of the V540A vaccine in healthy adults (V540A-001) Ended

2024-515785-14-00 Human Papilloma virus 1 2024-10-22
A clinical study of MK-3214 in healthy people (MK-3214-001) Ended

2024-516016-17-00 Hypercholesterolaemia 1 2024-10-22
A study to evaluate the safety and tolerability of JNJ-70035108 and to evaluate how long JNJ-70035108 stays in and acts on the body (pharmac… Ended

2024-514067-25-00 Inflammatory Conditions 1 2024-09-23
Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat… Ended

2024-514247-28-00 Asthma 3 2024-09-17
A study to test whether BI 456906 (survodutide) influences the amount of bupropion, caffeine and midazolam in the blood in people with overw… Ended

2024-512332-29-00 Overweight 3 2024-09-05
A study to learn if UCB3101 is safe and how it moves through the body of healthy participants Ended

2023-504586-24-00 Healthy Participants 1 2024-07-31
A study to test how well healthy people tolerate spesolimab when given in 2 different ways. Ended

2023-510448-20-00 Healthy volunteer trial 3 2024-07-30
A study to learn how safe KER-0193 is, the activity of KER-0193 in the body over a period of time, and the effect of KER-0193 to the body in… Ended

2024-511468-94-00 Fragile X syndrome 1 2024-07-10
Comparison of the study drug CHF 1535 formulated with two different propellants to learn about drug levels in blood and safety after inhalat… Ended

2023-510171-59-00 Asthma and chronic obstructive pulmonary disease (COPD) 3 2024-06-17
MK-7091 Formulations Study in Healthy Adult Participants Ended

2023-510402-40-00 Hypercholesterolemia 3 2024-06-07